Revvity
revvity.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
At Revvity, "impossible" is inspiration, and ""can't be done"" is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what's possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more.
News
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing
Read more
Report
Revvity outlines 2026 organic growth of 4% to 5% and adjusted EPS of $5.30 to $5.40, driven by diagnostics momentum and AI-linked demand (NYSE:RVTY)
Revvity (RVTY) Q2 2026 earnings call recap: raised FY organic growth and EPS guidance, AI-driven instrument backlog, tariff refund impact, and...
Read more
Report
Report
Revvity To Acquire ACD/Labs For Undisclosed Sum
(RTTNews) - Revvity, Inc. (RVTY), a diagnostic and health sciences company, Monday announced that it has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software solutions.
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.